Delisting rules should be made simpler, says JN Gupta

In an interview to CNBC-TV18, JN Gupta, former ED, Sebi spoke about the Astrazeneca Pharma delisting issue and its impact on the market.

In an interview to CNBC-TV18, JN Gupta, former ED, Sebi spoke about the  AstraZeneca Pharma  delisting issue and its impact on the market.

AstraZeneca stock price

On March 03, 2014, AstraZeneca Pharma closed at Rs 1110.90, up Rs 185.15, or 20.00 percent. The 52-week high of the share was Rs 1110.90 and the 52-week low was Rs 595.00.

The latest book value of the company is Rs 39.90 per share. At current value, the price-to-book value of the company was 27.84.

Anda sedang membaca artikel tentang

Delisting rules should be made simpler, says JN Gupta

Dengan url

https://untukkesehatanda.blogspot.com/2014/03/delisting-rules-should-be-made-simpler.html?m=0

Anda boleh menyebar luaskannya atau mengcopy paste-nya

Delisting rules should be made simpler, says JN Gupta

namun jangan lupa untuk meletakkan link

Delisting rules should be made simpler, says JN Gupta

sebagai sumbernya